
|Articles|October 15, 2009
- October 2009
- Volume 75
- Issue 10
DIABETES PRODUCTS
Advertisement
Articles in this issue
about 16 years ago
Case Studiesabout 16 years ago
Health Systems Product Newsabout 16 years ago
Women's Health Watchabout 16 years ago
Rx Product News Profile: A closer look at new FDA actions: Multaqabout 16 years ago
Cholesterol Watchabout 16 years ago
Biosimilars and Health Care Reformabout 16 years ago
Gestational Diabetes: What Patients Need to Knowabout 16 years ago
Blood Glucose Monitors for the Pediatric Populationabout 16 years ago
2-Minute Consultation: Preventive Foot Care for Diabetes Patientsabout 16 years ago
GERD WatchNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5





















































































































































































































